| Page 1495 | Kisaco Research
 

Luis Fernando Tamassia

Global Innovation Ruminants Lead
DSM Nutritional Products

Luis Fernando Tamassia

Global Innovation Ruminants Lead
DSM Nutritional Products

Luis Fernando Tamassia

Global Innovation Ruminants Lead
DSM Nutritional Products
 

Dr Flavia Saad

Professor in Pet Nutrition
Universidade Federal de Lavras

Dr Flavia Saad

Professor in Pet Nutrition
Universidade Federal de Lavras

Dr Flavia Saad

Professor in Pet Nutrition
Universidade Federal de Lavras
 

Francisco Jardim

Co-Founder and Managing Director
SP Ventures

Francisco Jardim

Co-Founder and Managing Director
SP Ventures

Francisco Jardim

Co-Founder and Managing Director
SP Ventures
 

Marcelo Ceccim

Advisor
CowMed

Marcelo Ceccim

Advisor
CowMed

Marcelo Ceccim

Advisor
CowMed
 

Daniel Ibri

Co-Founder & Managing Partner
Mindset Ventures

Daniel Ibri

Co-Founder & Managing Partner
Mindset Ventures

Daniel Ibri

Co-Founder & Managing Partner
Mindset Ventures
 

Cristina Jorge

Director
CMJ Consultoria & Assessoria

Cristina Jorge

Director
CMJ Consultoria & Assessoria

Cristina Jorge

Director
CMJ Consultoria & Assessoria
 

Ricardo Negri

Professor
ITBA

Ricardo Negri

Professor
ITBA

Ricardo Negri

Professor
ITBA
 

Josue Caride

CEO & Co-Founder
Sampp.co

Josue Caride

CEO & Co-Founder
Sampp.co

Josue Caride

CEO & Co-Founder
Sampp.co
 

Daniel Hato

Owner
Dr Hato Veterinary Hospital

Daniel Hato

Owner
Dr Hato Veterinary Hospital

Daniel Hato

Owner
Dr Hato Veterinary Hospital
 

John McIntosh

Biocatalytic synthesis of nucleotide therapeutics
Merck

For his PhD, John studied in Eric Schmidt’s laboratory at the University of Utah, where he studied the biosynthesis of the cyanobactin family of cyclic peptide natural products.

After finishing graduate school John was a postdoc in Frances Arnold’s laboratory at Caltech where he studied non-natural reactions of cytochrome P450s and other heme proteins.

John have been with Merck’s Small-Molecule Process Research and Development Department since 2015 where he has worked in the Biocatalysis and Protein Engineering groups. He is presently an associate principal scientist. 

John McIntosh

Biocatalytic synthesis of nucleotide therapeutics
Merck

John McIntosh

Biocatalytic synthesis of nucleotide therapeutics
Merck

For his PhD, John studied in Eric Schmidt’s laboratory at the University of Utah, where he studied the biosynthesis of the cyanobactin family of cyclic peptide natural products.

After finishing graduate school John was a postdoc in Frances Arnold’s laboratory at Caltech where he studied non-natural reactions of cytochrome P450s and other heme proteins.

John have been with Merck’s Small-Molecule Process Research and Development Department since 2015 where he has worked in the Biocatalysis and Protein Engineering groups. He is presently an associate principal scientist.